SHUKHRAT BOYMURADOV,MOHAMMED FALLAH,JUMABOEV NURILLO KHAYRULLO UGLI ,M.A BRUNO ,MS. TRIPTI DEWANGAN
DOI: https://doi.org/One of the most dangerous illnesses in the world is cardiovascular disease (CVD). Among the many adverse effects of the current treatment agent are bradycardia, arrhythmia, hypotension, and changes in various ion levels. In recent years, bioactive compounds derived from natural products—such as plants, microbes, and marine organisms—have gained prominence. Novel bioactive metabolites with a variety of pharmacological properties can be found in marine species. Sea-derived products including have shown amazing benefits against a variety of CVDs. The cardio-protective properties of marine-derived compounds against atherosclerosis, myocardial infarction, ischemic heart disease, and hypertension are currently given increased weight in reviews. In addition to therapies, the present state of sea-derived constituent usage, future prospects, and limitations have all been examined appropriately.
